New UBC research shows that people with MS see higher healthcare use up to 15 years before symptoms appear, highlighting opportunities for earlier identification and intervention. The earliest warning signs… Read More
DUBLIN, IE – Aon plc (NYSE: AON), a leading global professional services firm, today announced that Jo Ann Jenkins has been appointed to its Board of Directors, effective August 15, 2025. “We are pleased… Read More
Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint Treatment with VX-993 was generally safe and well tolerated, with safety profile… Read More
VANCOUVER, BC — Variational AI is proud to announce its participation in a new open science drug discovery initiative led by Agora Open Science Trust. The project is focused on optimizing the… Read More
By integrating VoxCell’s high-resolution 3D bioprinted tissue platforms into Altasciences’ discovery and preclinical services, both companies aim to reduce R&D timelines and increase the success rate of investigational therapies. LAVAL,… Read More
